Gemcitabine (2'-2'-difluorodeoxycytidine) is a well-known cytotoxic drug and a potent radio-enhancer. We herein report the in vitro evidence of its activity, and the clinical experiences when this drug is administered concurrently with radiation. The phase I-II trials are analyzed, focusing on the recent ability to deliver irradiation with low incidence of side effects.

Trodella, L., D'angelillo, R. M., Ramella, S., Cellini, N., Ciresa, M., Cesario, A., Granone, P., Chemo-radiotherapy in non-small cell lung cancer: the role of gemcitabine., <<ANNALS OF ONCOLOGY>>, 2006; (Maggio): 52-54 [http://hdl.handle.net/10807/5497]

Chemo-radiotherapy in non-small cell lung cancer: the role of gemcitabine.

Trodella;Lucio; D'Angelillo;Rolando Maria; Ramella;Sara; Cellini;Numa; Ciresa;Marzia; Cesario;Alfredo; Granone
2006

Abstract

Gemcitabine (2'-2'-difluorodeoxycytidine) is a well-known cytotoxic drug and a potent radio-enhancer. We herein report the in vitro evidence of its activity, and the clinical experiences when this drug is administered concurrently with radiation. The phase I-II trials are analyzed, focusing on the recent ability to deliver irradiation with low incidence of side effects.
Inglese
Trodella, L., D'angelillo, R. M., Ramella, S., Cellini, N., Ciresa, M., Cesario, A., Granone, P., Chemo-radiotherapy in non-small cell lung cancer: the role of gemcitabine., <<ANNALS OF ONCOLOGY>>, 2006; (Maggio): 52-54 [http://hdl.handle.net/10807/5497]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/5497
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 6
  • ???jsp.display-item.citation.isi??? 5
social impact